Blue Bell Private Wealth Management LLC Boosts Stock Position in Abrdn Life Sciences Investors (NYSE:HQL)

Blue Bell Private Wealth Management LLC grew its holdings in shares of Abrdn Life Sciences Investors (NYSE:HQL) by 97.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,244 shares of the company’s stock after buying an additional 30,750 shares during the period. Blue Bell Private Wealth Management LLC’s holdings in Abrdn Life Sciences Investors were worth $882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in HQL. Oppenheimer & Co. Inc. raised its position in shares of Abrdn Life Sciences Investors by 4.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 18,414 shares of the company’s stock worth $251,000 after acquiring an additional 814 shares in the last quarter. Commonwealth Equity Services LLC raised its holdings in Abrdn Life Sciences Investors by 2.6% during the second quarter. Commonwealth Equity Services LLC now owns 33,788 shares of the company’s stock worth $479,000 after purchasing an additional 868 shares in the last quarter. Kingsview Wealth Management LLC lifted its position in shares of Abrdn Life Sciences Investors by 2.5% during the 4th quarter. Kingsview Wealth Management LLC now owns 36,937 shares of the company’s stock worth $497,000 after buying an additional 904 shares during the last quarter. Future Financial Wealth Managment LLC purchased a new stake in shares of Abrdn Life Sciences Investors during the 1st quarter worth approximately $27,000. Finally, 180 Wealth Advisors LLC boosted its holdings in shares of Abrdn Life Sciences Investors by 2.8% in the 2nd quarter. 180 Wealth Advisors LLC now owns 136,231 shares of the company’s stock valued at $2,013,000 after buying an additional 3,682 shares in the last quarter. 32.21% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Abrdn Life Sciences Investors

In other Abrdn Life Sciences Investors news, major shareholder Saba Capital Management, L.P. purchased 13,812 shares of Abrdn Life Sciences Investors stock in a transaction on Monday, June 24th. The shares were bought at an average price of $14.08 per share, with a total value of $194,472.96. Following the completion of the acquisition, the insider now directly owns 3,429,891 shares of the company’s stock, valued at $48,292,865.28. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders have purchased a total of 27,666 shares of company stock valued at $387,754 in the last ninety days. 10.06% of the stock is currently owned by company insiders.

Abrdn Life Sciences Investors Stock Performance

Shares of HQL opened at $14.77 on Friday. Abrdn Life Sciences Investors has a 12-month low of $11.34 and a 12-month high of $15.90. The company’s 50 day simple moving average is $15.07 and its 200-day simple moving average is $14.10.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Friday, August 23rd will be issued a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 13.27%. The ex-dividend date of this dividend is Friday, August 23rd. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.